|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 10 |
| 1.1 List of Tables | 7 | 3 |
| 1.2 List of Figures | 10 | 2 |
| 2 Introduction | 12 | 1 |
| 2.1 What Is This Report About? | 12 | 1 |
| 3 Definitions of Markets Covered in the Report | 13 | 3 |
| 3.1 Neurology Devices | 13 | 1 |
| 3.2 CSF (Cerebro Spinal Fluid) Management | 13 | 1 |
| 3.2.1 Hydrocephalus shunt | 13 | 1 |
| 3.2.2 Intra Cranial Pressure (ICP) Monitors | 13 | 1 |
| 3.3 Interventional Neurology | 13 | 1 |
| 3.3.1 Aneurysm Clips | 13 | 1 |
| 3.3.2 Embolic System | 13 | 1 |
| 3.3.3 Navigational System | 13 | 1 |
| 3.4 Neurostimulation Device | 13 | 1 |
| 3.4.1 Spinal Cord Stimulator (SCS) | 14 | 1 |
| 3.4.2 Deep Brain Stimulator (DBS) | 14 | 1 |
| 3.4.3 Vagus Nerve stimulation (VNS) | 14 | 1 |
| 3.5 Neurosurgical Products | 14 | 1 |
| 3.5.1 Neuroendoscopes | 14 | 1 |
| 3.6 Radio surgery | 14 | 1 |
| 3.6.1 Cyber Knife | 14 | 1 |
| 3.6.2 GammaKnife | 14 | 2 |
| 4 Healthcare Sector Review | 16 | 9 |
| 4.1 Healthcare Expenditure | 16 | 4 |
| 4.2 Healthcare Infrastructure | 20 | 4 |
| 4.3 Healthcare Policy | 24 | 1 |
| 5 Regulation System | 25 | 4 |
| 5.1 Medical Equipment Approval Process | 25 | 1 |
| 5.1.1 Classification | 25 | 1 |
| 5.1.2 Premarket Notification for Class I Devices | 26 | 1 |
| 5.1.3 Pre-market Approval for Class II, III and IV Devices | 26 | 1 |
| 5.1.3.1 Technical Review: | 26 | 1 |
| 5.1.3.2 Type Testing: | 27 | 1 |
| 5.1.3.3 Applying for Product License: | 27 | 1 |
| 5.1.3.4 KGMP Certification | 27 | 1 |
| 5.1.4 License Fee | 27 | 1 |
| 5.1.5 License Application Processing Duration | 27 | 1 |
| 5.2 Post-market Surveillance | 28 | 1 |
| 6 Pricing and Reimbursement | 29 | 3 |
| 7 Distribution Structure | 32 | 1 |
| 7.1 Distribution Structure | 32 | 1 |
| 8 Neurology Devices In Republic of Korea | 33 | 9 |
| 8.1 Neurology Devices, Republic of Korea, Overall Revenue ($ mn), 2000-2015 | 33 | 6 |
| 8.2 Neurology Devices, Republic of Korea, Category Volume (Units), 2000-2015 | 39 | 2 |
| 8.3 Neurology Devices, Republic of Korea, Company Share (2007-2008) | 41 | 1 |
| 9 CSF Management In Republic of Korea | 42 | 7 |
| 9.1 CSF Management Overall Revenue (2000-2015) | 42 | 2 |
| 9.2 CSF Management Overall Volume (2000-2015) | 44 | 2 |
| 9.3 CSF Management Average Price (2000-2015) | 46 | 1 |
| 9.4 CSF Management Distribution Share (2007-2008) | 47 | 1 |
| 9.5 CSF Management, Republic of Korea, Company Share (2007-2008) | 48 | 1 |
| 10 Interventional Neurology In Republic of Korea | 49 | 15 |
| 10.1 Interventional Neurology Overall Revenue (2000-2015) | 49 | 2 |
| 10.1.1 Embolic Systems Revenue (2000-2015) | 51 | 2 |
| 10.1.2 Navigational Systems Revenue (2000-2015) | 53 | 2 |
| 10.2 Interventional Neurology Overall Volume (2000-2015) | 55 | 2 |
| 10.2.1 Embolic Systems Volume (2000-2015) | 57 | 2 |
| 10.2.2 Navigational Systems Volume (2000-2015) | 59 | 2 |
| 10.3 Interventional Neurology Average Price (2000-2015) | 61 | 1 |
| 10.4 Interventional Neurology Distribution Share (2007-2008) | 62 | 1 |
| 10.5 Interventional Neurology, Republic of Korea, Company Share (2007-2008) | 63 | 1 |
| 11 Neurostimulation Devices In Republic of Korea | 64 | 7 |
| 11.1 Neurostimulation Devices Overall Revenue (2000-2015) | 64 | 2 |
| 11.2 Neurostimulation Devices Overall Volume (2000-2015) | 66 | 2 |
| 11.3 Neurostimulation Devices Average Price (2000-2015) | 68 | 1 |
| 11.4 Neurostimulation Devices Distribution Share (2007-2008) | 69 | 1 |
| 11.5 Neurostimulation Devices, Republic of Korea, Company Share (2007-2008) | 70 | 1 |
| 12 Neurosurgical Products In Republic of Korea | 71 | 7 |
| 12.1 Neurosurgical Products Overall Revenue (2000-2015) | 71 | 2 |
| 12.2 Neurosurgical Products Overall Volume (2000-2015) | 73 | 2 |
| 12.3 Neurosurgical Products Average Price (2000-2015) | 75 | 1 |
| 12.4 Neurosurgical Products Distribution Share (2007-2008) | 76 | 1 |
| 12.5 Neurosurgical Products, Republic of Korea, Company Share (2007-2008) | 77 | 1 |
| 13 Radiosurgery In Republic of Korea | 78 | 5 |
| 13.1 Radiosurgery Overall Revenue (2000-2015) | 78 | 2 |
| 13.2 Radiosurgery Overall Volume (2000-2015) | 80 | 2 |
| 13.3 Radiosurgery Average Price (2000-2015) | 82 | 1 |
| 14 Overview of Key Companies in Republic of Korea Neurology Devices Market | 83 | 26 |
| 14.1 Integra LifeSciences Holdings Corporation | 83 | 1 |
| 14.1.1 Company Overview | 83 | 1 |
| 14.2 B. Braun Melsungen AG | 83 | 1 |
| 14.2.1 Company Overview | 83 | 1 |
| 14.3 Boston Scientific Corporation | 84 | 1 |
| 14.3.1 Company Overview | 84 | 1 |
| 14.3.2 Boston Scientific Corporation Pipeline Products | 85 | 1 |
| 14.3.2.1 Boston Scientific Corporation Pipeline Products By Equipment Type | 85 | 1 |
| 14.3.2.2 Boston Scientific Corporation Pipeline Products By Development Stage | 86 | 1 |
| 14.3.2.3 Boston Scientific Corporation Pipeline Products By Therapy Area | 87 | 1 |
| 14.3.2.4 Boston Scientific Corporation Pipeline Products By Clinical Trials | 88 | 1 |
| 14.3.2.5 Boston Scientific Corporation Pipeline Products By News Summary | 89 | 1 |
| 14.4 Medtronic, Inc. | 90 | 1 |
| 14.4.1 Company Overview | 90 | 1 |
| 14.4.2 Medtronic, Inc. Pipeline Products | 91 | 1 |
| 14.4.2.1 Medtronic, Inc. Pipeline Products By Equipment Type | 91 | 2 |
| 14.4.2.2 Medtronic, Inc. Pipeline Products By Development Stage | 93 | 2 |
| 14.4.2.3 Medtronic, Inc. Pipeline Products By Therapy Area | 95 | 2 |
| 14.4.2.4 Medtronic, Inc. Pipeline Products By Clinical Trials | 97 | 1 |
| 14.4.2.5 Medtronic, Inc. Pipeline Products By News Summary | 98 | 2 |
| 14.5 Accuray Incorporated | 100 | 1 |
| 14.5.1 Company Overview | 100 | 1 |
| 14.6 Cordis Corporation | 100 | 1 |
| 14.6.1 Company Overview | 100 | 1 |
| 14.7 Cyberonics, Inc. | 101 | 1 |
| 14.7.1 Company Overview | 101 | 1 |
| 14.7.2 Cyberonics, Inc. Pipeline Products | 101 | 1 |
| 14.7.2.1 Cyberonics, Inc. Pipeline Products By Equipment Type | 101 | 1 |
| 14.7.2.2 Cyberonics, Inc. Pipeline Products By Development Stage | 101 | 1 |
| 14.7.2.3 Cyberonics, Inc. Pipeline Products By Therapy Area | 101 | 1 |
| 14.8 OLYMPUS CORPORATION | 102 | 1 |
| 14.8.1 Company Overview | 102 | 1 |
| 14.9 KARL STORZ GmbH & Co. KG | 102 | 1 |
| 14.9.1 Company Overview | 102 | 1 |
| 14.10 St. Jude Medical, Inc. | 103 | 1 |
| 14.10.1 Company Overview | 103 | 1 |
| 14.10.2 St. Jude Medical Inc. Pipeline Products | 103 | 1 |
| 14.10.2.1 St. Jude Medical Inc. Pipeline Products By Equipment Type | 103 | 2 |
| 14.10.2.2 St. Jude Medical Inc. Pipeline Products By Development Stage | 105 | 1 |
| 14.10.2.3 St. Jude Medical Inc. Pipeline Products By Therapy Area | 106 | 1 |
| 14.10.2.4 St. Jude Medical Inc. Pipeline Products By Clinical Trials | 107 | 1 |
| 14.10.2.5 St. Jude Medical Inc. Pipeline Products By News Summary | 107 | 1 |
| 14.11 ev3 Inc. | 108 | 1 |
| 14.11.1 Company Overview | 108 | 1 |
| 14.12 Codman & Shurtleff, Inc | 108 | 1 |
| 14.12.1 Company Overview | 108 | 1 |
| 15 Appendix | 109 | 5 |
| 15.1 Global Markets Direct Research Methodology | 109 | 1 |
| 15.2 Secondary Research | 110 | 1 |
| 15.3 Primary Research | 110 | 1 |
| 15.4 Models | 111 | 1 |
| 15.5 Forecasts | 111 | 1 |
| 15.6 Expert Panel Validation | 111 | 1 |
| 15.7 Currency Conversion | 112 | 1 |
| 15.8 Contact Us | 113 | 1 |
| 15.9 Disclaimer | 113 | 1 |